Ads
related to: doctors against using semaglutide drugs for cancer
Search results
Results From The WOW.Com Content Network
New research published in has found evidence that the use of semaglutide medications, like Ozempic may help reduce the risk of obesity-associated cancers in people with type 2 diabetes.
That’s a legitimate concern given that research shows people who lost weight on 2.4 mg of semaglutide regained two-thirds of the weight they’d lost within a year of stopping the drug ...
The injectable drug, which is sold under the brand names Wegovy and Ozempic, is FDA-approved to help with weight loss and type 2 diabetes, but research and general use by the public has turned up ...
But some research has noted rare but serious side effects of once-weekly, 2.4-milligram (mg) semaglutide injections, such as pancreatitis, acute kidney injury, gallbladder issues, and thyroid cancer.
If you start taking a semaglutide medication like Ozempic, doctors stress that the medications are meant to be one tool you can use, alongside other healthy lifestyle changes. Chief among them ...
Semaglutide mimics a protein in your body called glucagon-like peptide 1 (GLP-1), explains Mir Ali, M.D., a bariatric surgeon and medical director of MemorialCare Surgical Weight Loss Center at ...